165 related articles for article (PubMed ID: 21156047)
21. Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy.
Camacho J; Moliné T; Bonaterra-Pastra A; Ramón Y Cajal S; Martínez-Sáez E; Hernández-Guillamon M
Front Neurol; 2019; 10():187. PubMed ID: 30918495
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein J (clusterin) and Alzheimer's disease.
Calero M; Rostagno A; Matsubara E; Zlokovic B; Frangione B; Ghiso J
Microsc Res Tech; 2000 Aug; 50(4):305-15. PubMed ID: 10936885
[TBL] [Abstract][Full Text] [Related]
23. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
[TBL] [Abstract][Full Text] [Related]
24. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier.
Zlokovic BV
Life Sci; 1996; 59(18):1483-97. PubMed ID: 8890929
[TBL] [Abstract][Full Text] [Related]
25. [Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients].
Zhu XQ; Zhou X; Zhao W; Zhang YM; Liu FJ; Cao J; Sun ZW
Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1156-1161. PubMed ID: 31006219
[No Abstract] [Full Text] [Related]
26. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
Poirier J
Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
[TBL] [Abstract][Full Text] [Related]
27. Association of complement factor H Y402H gene polymorphism with Alzheimer's disease.
Zetterberg M; Landgren S; Andersson ME; Palmér MS; Gustafson DR; Skoog I; Minthon L; Thelle DS; Wallin A; Bogdanovic N; Andreasen N; Blennow K; Zetterberg H
Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):720-6. PubMed ID: 18163432
[TBL] [Abstract][Full Text] [Related]
28. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
[TBL] [Abstract][Full Text] [Related]
29. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
[TBL] [Abstract][Full Text] [Related]
30. Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review.
Shafi O
BMC Neurol; 2016 Nov; 16(1):236. PubMed ID: 27875990
[TBL] [Abstract][Full Text] [Related]
31. Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies.
Nishida K; Quantock AJ; Dota A; Choi-Miura NH; Kinoshita S
Br J Ophthalmol; 1999 Oct; 83(10):1178-82. PubMed ID: 10502582
[TBL] [Abstract][Full Text] [Related]
32. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
Mulder SD; Veerhuis R; Blankenstein MA; Nielsen HM
Exp Neurol; 2012 Jan; 233(1):373-9. PubMed ID: 22101005
[TBL] [Abstract][Full Text] [Related]
33. The antimicrobial protection hypothesis of Alzheimer's disease.
Moir RD; Lathe R; Tanzi RE
Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
[TBL] [Abstract][Full Text] [Related]
34. Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly.
Zhan SS; Veerhuis R; Kamphorst W; Eikelenboom P
Neurodegeneration; 1995 Sep; 4(3):291-7. PubMed ID: 8581561
[TBL] [Abstract][Full Text] [Related]
35. Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans.
Vogelgesang S; Cascorbi I; Schroeder E; Pahnke J; Kroemer HK; Siegmund W; Kunert-Keil C; Walker LC; Warzok RW
Pharmacogenetics; 2002 Oct; 12(7):535-41. PubMed ID: 12360104
[TBL] [Abstract][Full Text] [Related]
36. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.
Pritchard A; Harris J; Pritchard CW; St Clair D; Lemmon H; Lambert JC; Chartier-Harlin MC; Hayes A; Thaker U; Iwatsubo T; Mann DM; Lendon C
Neurosci Lett; 2005 Jul; 382(3):221-6. PubMed ID: 15925094
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
Baum L; Chen L; Ng HK; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease.
Liao F; Yoon H; Kim J
Curr Opin Lipidol; 2017 Feb; 28(1):60-67. PubMed ID: 27922847
[TBL] [Abstract][Full Text] [Related]
39. Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
Tan L; Wang HF; Tan MS; Tan CC; Zhu XC; Miao D; Yu WJ; Jiang T; Tan L; Yu JT;
Sci Rep; 2016 May; 6():26027. PubMed ID: 27229352
[TBL] [Abstract][Full Text] [Related]
40. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
